Henry Shin, CEO
Henry Shin, CEO

STARmed’s radiofrequency expertise leads to cancer treatment technologies

  • STARmed has also developed a niche market for its improved gastroenterology endoscopic ablation device introduced in North America, Europe and Asia

Henry Shin, CEO
Henry Shin, CEO
READ FULL ARTICLE